.png){kind=icon}
.png){kind=icon}
Return
Formaldehyde, Epigenetics, and Alzheimer's Disease
.png){kind=icon}
OA
AI
DOI：10.1021/acs.chemrestox.9b00090.png)
.png){kind=icon}
.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
Alzheimer's disease (AD) is the most common form of dementia. The accumulation of beta-amyloid plaques and intracellular neurofibrillary tangles of hyperphosphorylated tau protein are two hallmarks of AD. The beta-amyloid and tau proteins have been at the center of AD research and drug development for decades. However, most of the clinical trials targeting beta-amyloid have failed. Whereas the safety and efficacy of most tau-targeting drugs have not yet been completely assessed, the first tau aggregation inhibitor, LMTX, failed in a late-stage trial, leading to further recognition of the complexities of AD and reconsideration of the amyloid hypothesis and perhaps the tau hypothesis as well. Multilevel complex interactions between genetic, epigenetic, and environmental factors contribute to the occurrence and progression of AD. Formaldehyde (FA) is a widespread environmental organic pollutant. It is also an endogenous metabolite in the human body. Recent studies suggest that elevation of FA in the body by endogenous and/or exogenous exposure may play important roles in AD development. We have demonstrated that FA reduces lysine acetylation of cytosolic histones, thereby compromising chromatin assembly and resulting in the loss of histone content in chromatin, a conserved feature of aging from yeast to humans. Aging is an important factor for AD progression. Therefore, FA-induced inhibition of chromatin assembly and the loss of histones may contribute to AD initiation and/or development. This review will briefly summarize current knowledge on mechanistic insights into AD, focusing on epigenetic alterations and the involvement of FA in AD development. The exploration of chemical exposures as contributing factors to AD may provide new insights into AD mechanisms and could identify potential novel therapeutic targets.
Keywords:
AMYLOID PRECURSOR PROTEIN
SENSITIVE AMINE OXIDASE
DNA METHYLATION
HISTONE ACETYLATION
REGULATES MEMORY
SYNAPTIC LOSS
TAU-PROTEIN
GLOBAL DNA
BETA
MICRORNA
AI Summary
Key information extracted from the uploaded paper, including a brief overview, abstract, background, key highlights, visual analysis, and future outlook.
Journal
IF:
3.8
Papers:
6.5K
Citations:
1.4W